{
  "id": "ef63b9b9f0fad14a",
  "title": "Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia ( CAH ) ",
  "description": "20251212T011500Z",
  "content": "",
  "source": "koreabizwire.com",
  "source_url": "http://koreabizwire.com/crinetics-announces-first-patient-dosed-in-pivotal-adult-trial-of-atumelnant-in-congenital-adrenal-hyperplasia-cah/339995",
  "published_at": "20251212T011500Z",
  "fetched_at": "2025-12-13T00:21:55.936102+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "South Korea",
  "raw_data": {
    "url": "http://koreabizwire.com/crinetics-announces-first-patient-dosed-in-pivotal-adult-trial-of-atumelnant-in-congenital-adrenal-hyperplasia-cah/339995",
    "url_mobile": "",
    "title": "Crinetics Announces First Patient Dosed in Pivotal Adult Trial of Atumelnant in Congenital Adrenal Hyperplasia ( CAH ) ",
    "seendate": "20251212T011500Z",
    "socialimage": "http://koreabizwire.com/wp/wp-content/uploads/2025/12/hq720-2.jpg",
    "domain": "koreabizwire.com",
    "language": "English",
    "sourcecountry": "South Korea"
  }
}